Baird analyst David Rescott upgraded LivaNova to Outperform from Neutral with a price target of $66, up from $55. The firm says management quantified growth levers in fiscal 2025 and beyond at its conference “that point to clear revenue upside over the next several years.” While LivaNova still will contend with an earnings headwind from the pending SNIA payout, the stock’s risk/reward is skewed to the upside as longer-term growth visibility becomes clearer. Baird now has more confidence in “defendable multiple expansion” for the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIVN:
- LivaNova Announces CHRO Hebbelinck’s Planned Departure and Benefits
- LivaNova jumps 5% to $49.15 after Baird note on CMS panel vote
- CMS vote on reimbursement could be win for LivaNova, says Baird
- CMS panel votes favorable for CVRx, says Lake Street
- LivaNova price target lowered to $55 from $57 at Baird